1-3 of 3
Authors: Wolfgang Tome
Journal Article
CTNI-48. SURVIVAL, TOXICITY, AND PATIENT REPORTED QOL OUTCOMES FOLLOWING PULSED REDUCED DOSE RATE RE-IRRADIATION WITH CONCURRENT BEVACIZUMAB FOR RECURRENT GRADE 4 GLIOMAS: RESULTS OF A PHASE II STUDY
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v86, https://doi.org/10.1093/neuonc/noad179.0330
Published: 10 November 2023
Journal Article
ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION & PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi24–vi25, https://doi.org/10.1093/neuonc/noz175.092
Published: 11 November 2019
Journal Article
NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi172, https://doi.org/10.1093/neuonc/noy148.716
Published: 05 November 2018
